Schott Pharma AG & CO KGaA Total Liabilities Growth & History (1SXP)

Schott Pharma AG & CO KGaA's total liabilities was €704.9M for fiscal 2025.

View full Schott Pharma AG & CO KGaA company overview

Schott Pharma AG & CO KGaA annual total liabilities history

Schott Pharma AG & CO KGaA annual total liabilities

Fiscal yearPeriod endedTotal liabilitiesChangeGrowth
20252025-09-30€704.9M€55.5M+8.54%
20242024-09-30€649.4M€109.8M+20.34%
20232023-09-30€539.6M€52.2M+10.71%
20222022-09-30€487.5M€167.0M+52.10%
20212021-09-30€320.5M€40.1M+14.31%
20202020-09-30€280.4M

Schott Pharma AG & CO KGaA total liabilities trends

Over the last five fiscal years, Schott Pharma AG & CO KGaA's total liabilities increased from €280.4M to €704.9M, a change of €424.5M. The latest reported quarter, Q3 2026, shows €696.1M.

About the metric

What total liabilities mean

Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.

Calculation and source

reported and calculated total liabilities

TickerStat uses total liabilities reported in company official filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Schott Pharma AG & CO KGaA source filings ↗

Community posts

It’s quiet here.

No posts about 1SXP yet. Start the conversation.

Write the first post